kinDOCK: a tool for comparative docking of protein kinase ligands
暂无分享,去创建一个
Laetitia Martin-Chanas | Gilles Labesse | Vincent Catherinot | G. Labesse | V. Catherinot | Laetitia Martin-Chanas
[1] W Patrick Walters,et al. CORES: an automated method for generating three-dimensional models of protein/ligand complexes. , 2004, Journal of medicinal chemistry.
[2] Asim Khwaja,et al. The Src-selective Kinase Inhibitor PP1 Also Inhibits Kit and Bcr-Abl Tyrosine Kinases* , 2003, The Journal of Biological Chemistry.
[3] M. Cotten,et al. Chemical Proteomic Analysis Reveals Alternative Modes of Action for Pyrido[2,3-d]pyrimidine Kinase Inhibitors* , 2004, Molecular & Cellular Proteomics.
[4] L. Johnson,et al. Protein Kinase Inhibitors: Insights into Drug Design from Structure , 2004, Science.
[5] J. Zheng,et al. Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. , 1991, Science.
[6] S. Hanks,et al. Protein kinase catalytic domain sequence database: identification of conserved features of primary structure and classification of family members. , 1991, Methods in enzymology.
[7] A. Elcock,et al. Rapid computational identification of the targets of protein kinase inhibitors. , 2005, Journal of medicinal chemistry.
[8] Gilles Labesse,et al. ViTO: tool for refinement of protein sequence-structure alignments , 2004, Bioinform..
[9] D. Diller,et al. Kinases, homology models, and high throughput docking. , 2003, Journal of medicinal chemistry.
[10] T Honma,et al. Crystallographic Approach to Identification of Cyclin-dependent Kinase 4 (CDK4)-specific Inhibitors by Using CDK4 Mimic CDK2 Protein* , 2001, The Journal of Biological Chemistry.
[11] J. Irwin,et al. Lead discovery using molecular docking. , 2002, Current opinion in chemical biology.
[12] E. Scholar,et al. Role of Tyrosine Kinase Inhibitors in Cancer Therapy , 2005, Journal of Pharmacology and Experimental Therapeutics.
[13] G. Milne,et al. Molecular modelling in drug design , 1989 .
[14] Adrian H Elcock,et al. Progress toward virtual screening for drug side effects , 2002, Proteins.
[15] A. Sali,et al. Protein Structure Prediction and Structural Genomics , 2001, Science.
[16] Claudio N. Cavasotto,et al. Protein flexibility in ligand docking and virtual screening to protein kinases. , 2004, Journal of molecular biology.
[17] Luhua Lai,et al. SCORE: A New Empirical Method for Estimating the Binding Affinity of a Protein-Ligand Complex , 1998 .
[18] G. Klebe,et al. Ligand-supported homology modelling of protein binding-sites using knowledge-based potentials. , 2003, Journal of molecular biology.
[19] Qing Zhang,et al. The RCSB Protein Data Bank: a redesigned query system and relational database based on the mmCIF schema , 2004, Nucleic Acids Res..
[20] A. W. Schüttelkopf,et al. PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. , 2004, Acta crystallographica. Section D, Biological crystallography.